FindTrial
Sign In

Effect of different doses of dexmedetomidine on bilateral superficial cervical plexus block for total thyroidetectomy

Effect of different doses of dexmedetomidine on bilateral superficial cervical plexus block for total thyroidetectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012646
Enrollment
Unknown
Registered
2017-09-12
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total thyroedectomy

Interventions

General anesthesia group:General anesthesia(inducted with sufentanil 5ug/kg+etomidate 2mg/kg + cisatriptan 2mg/kg,maintained with propofol 2ug/ml+remifentanil 3 ng/ml)
Control group:Ropivacaine 20ml for bilateral cervical plexus block(after induction, before surgery)
Low dose group:Dexmedetomedine 0.5ug/kg+0.5% ropivacaine 20ml for bilateral cervical plexus block(after induction, before surgery)
High dose group :Dexmedetomedine 1.0ug/kg+0.5% ropivacaine 20ml for bilateral cervical plexus block(after induction, before surgery)

Sponsors

Southern District of Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patient scheduled to for total thyroidectomy; 2. ASA physical status I-II; 3. Allergic history of dexmedetomidine; 4. Abnormal lever of thyroid hormones.

Exclusion criteria

Exclusion criteria: 1. History of cardiac, pulmonary, liver or renal disease; 2. Sinus bradycardia

Design outcomes

Primary

MeasureTime frame
VAS scale;—

Countries

China

Contacts

Public ContactLi Juan

Southern District of Anhui Provincial Hospital

huamuzi1999@126.com+86 13956005465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026